Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by Bradley Foster & Sargent Inc. CT

Bradley Foster & Sargent Inc. CT grew its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 35.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 62,898 shares of the company’s stock after purchasing an additional 16,613 shares during the quarter. Bradley Foster & Sargent Inc. CT owned approximately 0.05% of Privia Health Group worth $1,093,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. boosted its position in Privia Health Group by 1.1% during the first quarter. Vanguard Group Inc. now owns 11,400,035 shares of the company’s stock worth $223,327,000 after acquiring an additional 121,701 shares during the last quarter. Riverbridge Partners LLC boosted its holdings in shares of Privia Health Group by 17.5% during the 1st quarter. Riverbridge Partners LLC now owns 5,399,662 shares of the company’s stock worth $105,779,000 after purchasing an additional 804,304 shares during the last quarter. Norges Bank purchased a new stake in shares of Privia Health Group in the fourth quarter valued at approximately $27,959,000. Dimensional Fund Advisors LP increased its holdings in shares of Privia Health Group by 18.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after purchasing an additional 173,934 shares during the last quarter. Finally, First Light Asset Management LLC purchased a new position in Privia Health Group during the first quarter worth approximately $21,620,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the sale, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 14.20% of the company’s stock.

Analysts Set New Price Targets

PRVA has been the subject of several analyst reports. Evercore ISI dropped their target price on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Robert W. Baird raised their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Baird R W raised shares of Privia Health Group to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.86.

Privia Health Group Trading Up 1.9 %

PRVA stock opened at $19.44 on Friday. The business’s fifty day moving average price is $19.50 and its 200 day moving average price is $18.71. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $24.35. The company has a market capitalization of $2.32 billion, a PE ratio of 129.60, a P/E/G ratio of 4.40 and a beta of 0.77.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.02). The business had revenue of $422.30 million for the quarter, compared to analyst estimates of $411.50 million. Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.06 EPS. Research analysts predict that Privia Health Group, Inc. will post 0.16 EPS for the current fiscal year.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.